Generate a tailored SOP for Dr. Michael Freemark. Improve your application with a focused, well-structured draft.
Michael Scott Freemark is the Robert C. Atkins, M.D. Veronica Atkins Distinguished Professor Emeritus in the Department of Pediatrics at Duke University. He is an expert in childhood obesity and its management, particularly interested in the roles of placental and fetal hormones in the regulation of maternal metabolism and fetal growth. His research utilizes targeted knockout mice to investigate the molecular mechanisms by which hormones such as prolactin and placental lactogen affect pancreatic beta cell mass and insulin production throughout pregnancy and into postnatal life. Dr. Freemark has a significant clinical research portfolio focusing on the pathogenesis and treatment strategies for obesity and hyperlipidemia, encompassing the prevention of type 2 diabetes. He has demonstrated that metformin can aid in reducing fat stores and improving glucose and insulin levels in obese adolescents, decreasing their risk for developing diabetes. Freemark has also extensively studied the metabolic implications of genetic obesity disorders, such as Prader-Willi syndrome, and the intersection between malnutrition and health outcomes in impoverished children across various countries. He has published numerous papers and has been active in developing innovative screening tools for malnourished children globally.
Duke University • Durham, NC
Served as an academic and clinical leader in the Department of Pediatrics, focusing on pediatric endocrinology and childhood obesity.
Department of Biomedical Engineering (MS program)